๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

High-power Laser Therapy for Notalgia Paresthetica.

RecruitingNAAges 18 Years - 65 YearsAllUลŸak University
NCT07356362 on ClinicalTrials.gov โ†—
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

A non-invasive modality for the management of neuromusculoskeletal pain conditions that has emerged as a compelling option is high-power laser therapy (HPLT). The pathophysiology of notalgia paresthetica (NP) is treated uniquely by HPLT, which targets both the presumed muscular component of nerve entrapment and the resultant neuropathic symptoms. The main goal of this study, which is randomised, controlled and blinded by assessors, is to find out how well High-Power Laser Therapy (HPLT) works as an extra treatment to standard care in reducing itching, pain and improving quality of life for patients with long-term nerve pain.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18-75 years * Clinical diagnosis of unilateral Notalgia Paresthetica for at least 3 months * Presence of characteristic symptoms (pruritus, paresthesia, and/or burning pain) in the typical T2-T6 dermatomal distribution * A minimum score of 4 on the Numeric Rating Scale (NRS) for pruritus intensity * Presence of hyperpigmentation in the affected area Exclusion Criteria: * \- Secondary causes of symptoms (e.g., spinal pathology, herpes zoster, renal failure) * Previous spinal surgery in the thoracic region * Coagulopathy or use of anticoagulant medication * Skin diseases or infections in the treatment area * Pregnancy or lactation * Cognitive impairment affecting ability to complete questionnaires * Previous treatment with botulinum toxin in the affected area within 6 months
๐Ÿ’Š

What it tests

  • High-power laser
  • Sham Laser
๐Ÿ“

Where

1 site
Usak University
UลŸak, Turkey (Tรผrkiye)
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy